Trial Profile
Open Label, 2-Way Crossover Study to Assess the PK of Intranasal Ketorolac Tromethamine and to Assess the Effects of a Single Dose of Oxymetazoline Hydrochloride on the PK of Intranasal Ketorolac Tromethamine in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Apr 2019
Price :
$35
*
At a glance
- Drugs Ketorolac (Primary) ; Oxymetazoline
- Indications Acute pain
- Focus Pharmacokinetics
- Sponsors American Regent; Luitpold Pharmaceuticals
- 03 Jun 2011 New trial record